Glenn Sussman

Piper Sandler & Co. (Broker) (PSC-Broker) is the full-service brokerage division of Piper Sandler & Co., a financial service firm headquartered in Minneapolis, Minnesota. They are a subsidiary of Piper Sandler Companies (NYSE: PIPR). The firm was founded in 1969 and previously known as Piper Jaffray & Co. They became Piper Sandler & Co. when Piper Jaffray Companies and Sandler O’Neill & Partners, L.P. merged to become Piper Sandler Companies in 2020. PSC-Broker provides brokerage and investment banking services to financial institutions, corporations and other financial investors. Their core focus sectors are Agriculture, renewables & cannabis, Business services, Chemicals & Materials, Consumer, Diversified industrials & services, Energy, Financial services, financial sponsors, Healthcare, and Technology.

Agile RF, Inc. designs and fabricates tunable integrated components. It offers tunable components that can be designed into circuit boards or retrofitted to augment existing boards. The firm's products include Tunable Matching Networks, Phase Shifters, Tunable Filters, and CSIP. The company was founded by Chris R. Elsassin 1999 and is headquartered in Goleta, CA.

SteriFx, Inc. manufactures pathogen control systems. The company was founded in 2001 and is headquartered in Shreveport, LA.

Iosil Energy Corp. manufactures and markets solar grade polysilicon. It specializes in the development of technologies for the production of high purity virgin polysilicon. The firm’s solutions are from the waste material or kerf created by wafer sawing operations. The company was founded by William G. Kingsley and John Fallavolita in 2007 and is headquartered in Groveport, OH.

Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA.

SpectraFluidics, Inc. produces cement. It offers hydraulic cements, including Portland cement, aluminous cement, slag cement and cement oversulfated. The company was founded by Sanjoy Banerjee, Seung Joon Lee, Carl Meinhart, Martin Moskovits, Brian D. Piorek and Juan G. Santiago in 2007 and is headquartered in Goleta, CA.

Lixivia, Inc. provides proprietary processes and bio-derived/inspired chemicals. The company was founded in 2012 and is headquartered in Santa Barbara, CA.

Part of Medtronic Plc, EndoTherapeutics is a laparoscopic surgical concern. The company is based in Menlo Park, CA. The company was founded by Frederic H. Moll.

Morgan Stanley Venture Partners (MSVP) is a venture capital firm subsidiary of Morgan Stanley Investment Management Merchant Banking, which is ultimately owned by Morgan Stanley (NYSE: MWD) founded in 1986.The firm is headquartered in New York.

New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.

University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH.

Cycad Group LLC (Cycad Group) is a venture capital firm founded in the year 2000 by Paul F. Glenn, K. Leonard Judson and Mark R. Collins. The firm is headquartered in Santa Barbara, California.

Mark Products Corp. is a supplier of LCD modules for electronics OEMs. The private company is based in Wood Dale, IL. The company has created a new website to provide important company, product, and market information to enable engineering and purchasing professionals to make intelligent sourcing decisions in the rapidly changing LCD industry. The company's mission is to address the STN LCD module needs of leading OEMs and emerging firms in the electronics industry by providing consistent, high-quality STN LCD products exclusively from Nan Ya Plastics Corporation, innovative technical solutions to customer design requirements, application and design-in support from industry technical experts, and world-class pricing and customer service.

Taraval Associates LLC (Taraval Associates) is a venture capital firm founded in 1989 by George Murphy. The firm is headquartered in Menlo Park, California.

Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom.

Sofie Biosciences, Inc. operates as a diagnostics company that provides molecular imaging probes and devices to help scientists and physicians investigate the biology of disease. It combines the discovery and development of new PET imaging probes with innovative imaging systems and chemistry platforms to provide researchers and physicians with tools to better understand the biology of disease. The company was founded by Owen N. Witte, Michael E. Phelps, Jim Heath, Johannes Czernin, and Caius Radu in 2008 and is headquartered in Culver City, CA.

Cardionomic, Inc. engages in the development of medical devices. The company was founded in 2011 and is headquartered in New Brighton, MN.

Aurea Medical LLC provides medical devices for treatment of ophthalmic diseases and disorders. The company is headquartered in Denver, CO.

New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich.

Vensana Capital Management LLC (Vensana Capital) is a venture capital and growth equity investment firm founded in 2019 by Peter Klein Justin & Kirk G. Nielsen. The firm is headquartered in Saint Paul, Minnesota.

Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA.

Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022.

Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane.

Nexo Therapeutics is a small molecule oncology company that focuses on discovering and developing new drugs for cancer patients who do not have effective treatments. The company is based in Littleton, CO and Watertown, MA. The company uses covalent ligand discovery, chemical biology, cancer biology, and medicinal chemistry to target the underlying causes of cancer through innovative methods. Nexo Therapeutics was founded by John Athanosopoulos, Andrew J. Phillips, Michael Kim, and Rhamy Zeid. Andrew J. Phillips has been the CEO of the company since 2022.